Mukhtarova, Liliya A.,
Fedorova, Yulia Yu.,
Karunas, Aleksandra S.,
Prokofyeva, Darya S.,
Nurgalieva, Alfia Kh.,
Khusnutdinova, Elza K.,
Zagidullin, Shamil Z. (2023) for each
outcome. Conclusion — As a result of regression analysis, significant clinical and prognostic risk
Timasheva, Yanina,
Kochetova, Olga,
Balkhiyarova, Zhanna,
Korytina, Gulnaz,
Prokopenko, Inga,
Nouwen, Arie (2025) .11, p = 0.507). Conclusions: Polygenic scores could aid in predicting MetS risk and health
outcomes personalized treatment strategies and improving patient
outcomes. © 2024 The Authors
Ivanova, E.,
Gilyazova, I.,
Pavlov, V.,
Izmailov, A.,
Gimalova, G.,
Karunas, A.,
Prokopenko, I.,
Khusnutdinova, E. (2022) risk of developing disease
outcomes from the general population. Clear cell renal cell carcinoma (cc
Mukhametov, Ural,
Lyulin, Sergey,
Borzunov, Dmitry,
Ilyasova, Tatiana,
Gareev, Ilgiz,
Sufianov, Albert (2023) to improving patient
outcomes through the development of new therapies and improved resuscitation strategies
years, study design, medical conditions, involved drugs,
outcome measure, and subject information were
Jonas, Jost B.,
Bikbov, Mukharram M.,
Kazakbaeva, Gyulli M.,
Wang, Ya Xing,
Xu, Jie,
Jonas, Rahul A.,
Panda-Jonas, Songhomitra (2024) aged 40+ years, and the Ural Very Old Study (UVOS) examined individuals aged 85+ years. Main
outcomeGao, Xin,
Huang, Yanming,
Wei, Tonghui,
Xue, Jingmin,
Iurii, Filippov,
Yang, Laishou,
Wang, Liying,
Li, Hao,
Mo, Genshen,
Huang, Yuze,
Xie, Haonan,
Wang, Hang,
Lou, Shenghan,
Han, Peng (2025) progression and chemoresistance, highlighting potential therapeutic targets for improving treatment
outcomes